Drug
Empagliflozin Metformin Hydrochloride Combination
Empagliflozin Metformin Hydrochloride Combination: highest development phase Phase 1, developed by Gedeon Richter. 3 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Gedeon Richter
Trials
| Drug | Phase | Indication |
|---|---|---|
| Empagliflozin + Metformin hydrochloride 5 mg/1000 mg combination film-coated tablets NCT06792968 | Phase 1 | Diabetes Mellitus Type 2 |
| Empagliflozin + Metformin hydrochloride 5 mg/850 mg combination film-coated tablets NCT06766500 | Phase 1 | Diabetes Mellitus Type 2 |
| Empagliflozin + Metformin hydrochloride 12.5 mg/1000 mg combination film-coated tablets NCT06823856 | Phase 1 | Diabetes Mellitus Type 2 |
Latest
No recent events.
Follow Empagliflozin Metformin Hydrochloride Combination on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.